The HIV/AIDS Diagnostics market studied was projected to grow with a CAGR of nearly 8.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the prevalence of HIV and AIDS globally. According to UNAIDS, 37.9 million people globally were affected with HIV, 1.7 million became newly infected with HIV, 770 000 people died from AIDS-related illnesses by the end of 2018. Furthermore, the growing initiatives by the government in this section are boosting the market growth. India’s AIDS Control Programme is globally praised as a success story. The National AIDS Control Programme (NACP), is being implemented as a thorough program for the prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV. However, the lack of mandates for the nucleic acid test in developing countries is the major drawback of the market growth.

Key Market Trends

Antibody Test segment is accounting for the largest segment of the Market

  • The Antibody test detects HIV antibodies in your blood or saliva. The immune system makes antibodies when bacteria or viruses enter the body. An HIV antibody test can determine if the person is positive after 3–12 weeks after infection. That’s because it can take a few weeks or longer for the immune system to make antibodies to HIV. The patient is able to do an HIV antibody test in the privacy at home with the kits.
  • The dominance in the market growth can be attributed to the increase in the prevalance of HIV/AIDS globally, and the efficacy of the antigen testing. Furthemore, the rise in the government initiatives and programs is boosting the global market. For instance African heads of state have approved two major new programs to help end AIDS by 2030. The community health employees initiative aims to recruit, train and deploy 2 million community health workers across Africa by 2020. The western and central Africa catch-up plan aims to rapidly accelerate access to HIV treatment in the region and close the gap in access between African regions.



North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of HIV/AIDS in the region, established healthcare infrastructure are some of the key factors accountable for its large share. According to the latest estimates from the Centers for Disease Control and Prevention, 37,832 people received an HIV diagnosis in the United States, in 2018. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Competitive Landscape

The HIV/AIDS diagnostics market is moderately competitive and consists of several major players. Some of the market players are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Hologic Inc., and Bio-Rad Laboratories

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support